These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. [The effects of ticlopidine on platelet aggregation: study on 13 atherosclerotic patients]. Lenci R; Galante A; Borzi M; Ariganello M; Sommariva L; Filice A; Cannata D Clin Ter; 1983 Feb; 104(3):205-9. PubMed ID: 6861457 [No Abstract] [Full Text] [Related]
5. Rationale for the use of drugs inhibiting platelet function in claudicating patients with atherosclerotic leg arteries. Verstraete M Agents Actions Suppl; 1984; 15():173-87. PubMed ID: 6091423 [No Abstract] [Full Text] [Related]
6. [Ticlopidine in the prevention of recurrent cerebral ischemic accidents]. Herce Muñoz M Med Clin (Barc); 1984 Oct; 83(12):517-8. PubMed ID: 6513628 [No Abstract] [Full Text] [Related]
11. The North American ticlopidine aspirin stroke study: structure, stratification variables, and patient characteristics. Hass WK; Kamm B Agents Actions Suppl; 1984; 15():273-8. PubMed ID: 6385651 [No Abstract] [Full Text] [Related]
12. Ticlopidine: quo vadis? Subarachnoid hemorrhage. Ono H; Mizukami M; Kitamura K; Kikuchi H Agents Actions Suppl; 1984; 15():259-72. PubMed ID: 6385650 [No Abstract] [Full Text] [Related]
13. A double-blind trial of ticlopidine in sickle cell disease. Semple MJ; Al-Hasani SF; Kioy P; Savidge GF Thromb Haemost; 1984 Jul; 51(3):303-6. PubMed ID: 6388012 [TBL] [Abstract][Full Text] [Related]
14. Clinical and biological double-blind-study of ticlopidine in preventive treatment of sickle-cell disease crises. Cabannes R; Lonsdorfer J; Castaigne JP; Ondo A; Plassard A; Zohoun I Agents Actions Suppl; 1984; 15():199-212. PubMed ID: 6385647 [No Abstract] [Full Text] [Related]
15. Therapeutic effect of ticlopidine for ischemic leg ulcers. Katsumura T Agents Actions Suppl; 1984; 15():167-72. PubMed ID: 6385645 [No Abstract] [Full Text] [Related]
16. Ticlopidine in the secondary prevention of early diabetes-related microangiopathy: protocol of a multicenter therapeutic study (TIMAD study). Mirouze J Agents Actions Suppl; 1984; 15():230-58. PubMed ID: 6385649 [No Abstract] [Full Text] [Related]
17. Evaluation of the antithrombotic efficacy of ticlopidine in man. Panak E; Blanchard J; Roe RL Agents Actions Suppl; 1984; 15():148-66. PubMed ID: 6385644 [No Abstract] [Full Text] [Related]
18. The effect of ticlopidine on platelet functions in acute myocardial infarction. A double blind controlled trial. Knudsen JB; Kjøller E; Skagen K; Gormsen J Thromb Haemost; 1985 Jun; 53(3):332-6. PubMed ID: 3901391 [TBL] [Abstract][Full Text] [Related]
19. Ticlopidine: a promise for the prevention and treatment of thrombosis and its complications. Panak E; Maffrand JP; Picard-Fraire C; Vallée E; Blanchard J; Roncucci R Haemostasis; 1983; 13 Suppl 1():1-54. PubMed ID: 6642292 [No Abstract] [Full Text] [Related]
20. The effect of ticlopidine on TIA compared with aspirin: a double-blind, twelve-month follow-up study. Tohgi H Agents Actions Suppl; 1984; 15():279-82. PubMed ID: 6385652 [No Abstract] [Full Text] [Related] [Next] [New Search]